Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV000684965 | SCV000812430 | pathogenic | Charcot-Marie-Tooth Neuropathy X | 2022-08-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Met34 amino acid residue in GJB1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8829637, 9361298, 12460545). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects GJB1 function (PMID: 12460545). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 565409). This missense change has been observed in individuals with X-linked Charcot-Marie-Tooth disease (PMID: 9018031, 11571214). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 34 of the GJB1 protein (p.Met34Val). |
| Ce |
RCV001172018 | SCV001334947 | pathogenic | not provided | 2020-03-01 | criteria provided, single submitter | clinical testing | |
| Inherited Neuropathy Consortium | RCV000789244 | SCV000928596 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |